13-valent pneumococcal conjugate vaccine (Sinovac Biotech)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name13-valent pneumococcal conjugate vaccine (Sinovac Biotech)
Drug Alias Namepneumococcal conjugate vaccine (Sinovac)PCV
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSinovac Biotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinovac Biotech Ltd
Inactive CompaniesN/A
Active IndicationsPneumococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A